Last reviewed · How we verify
Oral capsule faecal microbiota transplantation — Competitive Intelligence Brief
phase 3
Gastroenterology
Biologic
Live · refreshed every 30 min
Target snapshot
Oral capsule faecal microbiota transplantation (Oral capsule faecal microbiota transplantation) — Tan Tock Seng Hospital. Oral capsule faecal microbiota transplantation involves the transfer of live microbes from a donor into the patient's gastrointestinal tract to restore a healthy balance of gut bacteria.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oral capsule faecal microbiota transplantation TARGET | Oral capsule faecal microbiota transplantation | Tan Tock Seng Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oral capsule faecal microbiota transplantation CI watch — RSS
- Oral capsule faecal microbiota transplantation CI watch — Atom
- Oral capsule faecal microbiota transplantation CI watch — JSON
- Oral capsule faecal microbiota transplantation alone — RSS
Cite this brief
Drug Landscape (2026). Oral capsule faecal microbiota transplantation — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-capsule-faecal-microbiota-transplantation. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab